- Clinical Hematology & Oncology 2024
- Melanoma 2024: 34th Annual Cutaneous Malignancy Update
- 2023 Cancer Care Symposium
- 2023 Oncology Update
- Clinical Hematology & Oncology 2023
- Melanoma 2023: 33rd Annual Cutaneous Malignancy Update
- 2022 Cancer Care Symposium
- Clinical Hematology & Oncology 2022
- Melanoma 2022: 32nd Annual Cutaneous Malignancy Update
- 2021 Cancer Care Symposium
- Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
- Eighth Annual Scripps Cancer Care Symposium
- Melanoma 2020: 30th Annual Cutaneous Malignancy Update
- 7th Annual Scripps Cancer Care Symposium
- 2019 Oncology Update
- Melanoma 2019: 29th Annual Cutaneous Malignancy Update
- Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
- Videos
- Events
Playback speed
10 seconds
ASCO HR+/HER2 Breast Review: Practice Changing Monalessa-7 Trial Ribociclib + Endocrine Therapy Superior PFS/OFS in Premenopausal Women & Alpelisib for PIK3 Mutated Advanced Breast Cancer
650 views
August 14, 2019
Login to view comments.
Click here to Login
2019 Oncology Update Videos